Anavex Life Sciences
AVXL
AVXL
135 hedge funds and large institutions have $370M invested in Anavex Life Sciences in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 45 increasing their positions, 29 reducing their positions, and 17 closing their positions.
Holders
135
Holders Change
+9
Holders Change %
+7.14%
% of All Funds
2.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
45
Reduced
29
Closed
17
Calls
$19M
Puts
$18.2M
Net Calls
+$840K
Net Calls Change
+$667K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$71.6M |
| 2 |
2
Charles Schwab
San Francisco,
California
|
$8.96M |
| 3 |
PC
3
Pier Capital
Stamford,
Connecticut
|
$4.96M |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$3.21M |
| 5 |
5
Nomura Holdings
Tokyo,
Japan
|
$2.69M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
XS
151
XR Securities
Chicago,
Illinois
| – | – | – | – |
|
152
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
153
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
EI
154
Ellevest Inc
New York
| $0 | 25 | +2 | +9% |
|
155
US Bancorp
Minneapolis,
Minnesota
| $0 | 27 | +27 | New |
|